BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, March 13, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 3, 2001
View Archived Issues
Enhanced version of MetXia to be codeveloped by Oxford BioMedica and PolyMASC
Read More
Bioniche bladder cancer trial yields positive interim results
Read More
NIH funds will be used to advance development of novel HIV treatments at PTC
Read More
Favorable preclinical results reported for Demegen's vaginal microbicide
Read More
Genta licenses technology platform for designing novel anticancer treatments
Read More
IND filed to investigate Hemolink in chemotherapy-associated anemia
Read More
BLA for Zevalin granted priority review by FDA
Read More
Pharmacokinetics of Co-102862 investigated in animals using new HPLC method
Read More
Update on status of Fabrazyme reported by Genzyme General
Read More
Pregabalin may have beneficial effects in the treatment of abdominal pain
Read More
Pivotal trial of Ortec's donor site wound treatment shows promising results; PMA filing upcoming
Read More
Preclinical studies on interaction of STI-571 with chemotherapeutic agents and radiation
Read More
TKT to commence clinical trials of Hunter's syndrome treatment
Read More
Remicade is first drug approved for inhibiting progression of joint damage in RA
Read More
TRIAD compositions with neuroprotective efficacy reported by Quebec researchers
Read More
Centocor acquires worldwide rights to 3DP's orally active direct thrombin inhibitor program
Read More
Hydroxamic acid-based MMP inhibitors with selectivity for MMP-2, MMP-9 and/or MMP-13
Read More
New agents for HIV and AIDS interact with CCR5 receptor
Read More
Kyowa Hakko synthesizes phenylalanine esters intended for atopic dermatitis
Read More
Gestilab patents compositions protecting against myocardial oxidative stress
Read More
NCI funds development of novel vector that enhances tumor cell radiosensitivity
Read More
Cell Genesys reports further promising results from phase I trial of GVAX pancreatic cancer vaccine
Read More
FDA agrees to review BLA for first intranasal flu vaccine
Read More
